Prevalence and molecular correlates of acquired EGFR resistance mutations in non-small cell lung cancer (NSCLC).

Saved in:
Bibliographic Details
Title: Prevalence and molecular correlates of acquired EGFR resistance mutations in non-small cell lung cancer (NSCLC).
Authors: Raez LE; Thoracic Oncology Program, Memorial Cancer Institute/Florida Atlantic University, Miami, FL, USA., Baca Y; Caris Life Sciences, Phoenix, AZ, USA., Ribeiro JR; Caris Life Sciences, Phoenix, AZ, USA., Nieva JJ; Norris Cancer Center, University of Southern California, Los Angeles, CA, USA., Mamdani H; Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA., Lopes G; University of Miami Miller School of Medicine, Miami, FL, USA., Borghaei H; Fox Chase Cancer Center, Philadelphia, PA, USA., Socinski M; AdventHealth Cancer Institute, Orlando, FL, USA., Wozniak AJ; Hillman Cancer Center University of Pittsburgh, Pittsburgh, PA, USA., Vanderwalde A; Caris Life Sciences, Phoenix, AZ, USA., Uribe CC; Memorial Healthcare System, Pembroke Pines, FL, USA., Sumarriva D; Caris Life Sciences, Phoenix, AZ, USA., Khan H; Warren Alpert Medical School, Brown University, Providence, RI, USA., Liu SV; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA., Nagasaka M; University of California Irvine School of Medicine and Chao Family Comprehensive Cancer Center, Orange, CA, USA.
Source: Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2025 Jun; Vol. 25 (6), pp. 711-718. Date of Electronic Publication: 2025 Apr 17.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first